These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Coexistence of diabetes mellitus type 1 with diffuse systemic sclerosis - case report and literature review. Wielosz E; Kurowska M; Suszek D; Majdan M Reumatologia; 2017; 55(2):104-107. PubMed ID: 28539684 [TBL] [Abstract][Full Text] [Related]
47. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications. Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153 [TBL] [Abstract][Full Text] [Related]
48. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis. Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043 [TBL] [Abstract][Full Text] [Related]
50. Scleroderma and primary biliary cirrhosis. Murray-Lyon IM; Thompson RP; Ansell ID; Williams R Br Med J; 1970 Aug; 3(5717):258-9. PubMed ID: 5448799 [TBL] [Abstract][Full Text] [Related]
51. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review. Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039 [TBL] [Abstract][Full Text] [Related]
52. Raynaud's phenomenon and systemic sclerosis. Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438 [TBL] [Abstract][Full Text] [Related]
53. Raynaud's phenomenon and scleroderma; a case report and psychodynamic formulation. RICHARDSON HB Psychoanal Rev; 1955 Jan; 42(1):24-38. PubMed ID: 14371880 [No Abstract] [Full Text] [Related]
54. [Calcinosis, Raynaud's phenomenom, sclerodactylia and telangiectasia in progressive systemic sclerosis. Statistical analysis of contingencies]. Mintz G Gac Med Mex; 1976 Jun; 107(6):525-36. PubMed ID: 976673 [No Abstract] [Full Text] [Related]
55. Raynaud phenomenon and the vascular disease in scleroderma. Kahaleh MB Curr Opin Rheumatol; 2004 Nov; 16(6):718-22. PubMed ID: 15577610 [TBL] [Abstract][Full Text] [Related]
56. [Use of defibrotide in the treatment of Raynaud's phenomenon associated with progressive systemic sclerosis or essential mixed cryoglobulinemia]. Ranieri G; De Mitrio V; Petronelli M; Ancona A; Dammacco F Clin Ter; 1988 Sep; 126(5):335-43. PubMed ID: 2973963 [No Abstract] [Full Text] [Related]
58. [Perioperative management of a patient with transient polyuria]. Fukuda T; Okutani R; Kono K; Ishida H Masui; 1992 Aug; 41(8):1305-10. PubMed ID: 1433856 [TBL] [Abstract][Full Text] [Related]
59. Bilateral aseptic necrosis of the lunate in systemic sclerosis. Agus B Clin Exp Rheumatol; 1987; 5(2):155-7. PubMed ID: 3608271 [TBL] [Abstract][Full Text] [Related]
60. [Systemic sclerosis - a rare but important diagnosis in primary health care]. Andreasson K; Lillpers K; Wollheim F; Hesselstrand R Lakartidningen; 2019 Sep; 116():. PubMed ID: 31573670 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]